Spectrofluorometric Turn-Off Sensing Probe for Tolmetin Determination Using Cerium and Nitrogen Codoped Carbon Dots
- PMID: 39472300
- DOI: 10.1002/bio.70008
Spectrofluorometric Turn-Off Sensing Probe for Tolmetin Determination Using Cerium and Nitrogen Codoped Carbon Dots
Abstract
A facile, low-cost, and rapid method was developed for spectrofluorometric determination of tolmetin (TOL) using highly fluorescent (QY = 35%) cerium and nitrogen codoped carbon dots (Ce-NCDs) sensing platform prepared by one-step hydrothermal method. Owing to the severe overlap between TOL absorption and Ce-NCDs excitation spectra around 320 nm, TOL could attenuate the emission of Ce-NCDs at 407 nm through primary inner filter effect (IFE). This concentration dependent attenuation was linear between 2 and 10 μg/mL (r = 0.9993) with a limit of detection of 0.5 μg/mL. The sensor showed very good accuracy (% recovery = 98%-100%) and precision (%RSD < 2). The developed sensing strategy was successfully applied for TOL detection as an active pharmaceutical ingredient in pharmaceutical formulation and as a potential pollutant in environmental water samples, such as tap and river water, with acceptable recovery and considerable selectivity. Thus, the direct single-step spectrofluorometric determination of TOL was enabled without extensive processing or chemical derivatization.
Keywords: cerium doped carbon dot; inner filter effect; quenching; spectrofluorometry; tolmetin.
© 2024 John Wiley & Sons Ltd.
References
-
- J. E. Levinson, J. Baum, E. Brewer, C. Fink, V. Hanson, and J. Schaller, “Comparison of Tolmetin Sodium and Aspirin in the Treatment of Juvenile Rheumatoid Arthritis,” The Journal of Pediatrics 91 (1977): 799–804, https://doi.org/10.1016/S0022‐3476(77)81045‐7.
-
- S. M. Katz, “Tolmetin,” Journal of the American Medical Association 246 (1981): 243, https://doi.org/10.1001/jama.1981.03320030035024.
-
- A. A. Ramadan, A. M. Elbakry, A. H. Esmaeil, and S. A. Khaleel, “Pharmaceutical and Pharmacokinetic Evaluation of Novel Rectal Mucoadhesive Hydrogels Containing Tolmetin Sodium,” Journal of Pharmaceutical Investigation 48 (2018): 673–683, https://doi.org/10.1007/s40005‐017‐0365‐1.
-
- M. Bakhriansyah, P. C. Souverein, M. W. F. van den Hoogen, A. de Boer, and O. H. Klungel, “Risk of Nephrotic Syndrome for Non‐steroidal Anti‐inflammatory Drug Users,” Clinical Journal of the American Society of Nephrology 14 (2019): 1355–1362, https://doi.org/10.2215/CJN.14331218.
-
- D. A. Feinfeld, L. Olesnicky, C. L. Pirani, and G. B. Appel, “Nephrotic Syndrome Associated With Use of the Nonsteroidal Anti‐inflammatory Drugs,” Nephron 37 (1984): 174–179, https://doi.org/10.1159/000183239.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous